SOBRE ESTE PODCAST 🔗

Apresentadores:
Frequência de atualização:
monthly
Duração média do áudio:
20 minutes
Entrevistas com convidados
Tem patrocinadores
Inglês
Estados Unidos da América
13 episódios
desde 14 de Abril de 2025
episodic

ÚLTIMO EPISÓDIO 🔗

In this special Crimes Against Innovation episode, host Nicola Hill hears two charges against pharma. Erik Janssen, UCB’s Vice President and Head of Digital Care Transformation, argues that ‘pilotitis’ is 'the most expensive way to look innovative’, with organizations trapped in pilots that generat…

PESQUISAR EPISÓDIOS PASSADOS

Pesquisar episódios anteriores de Hypothesize That!.

EPISÓDIOS ANTERIORES

AI can already diagnose some conditions faster than humans. Robots are entering hospitals. So, are we heading towards a future without doctors? Nicola Hill sits down with UCB's Vice President and Head of Digital Care Transformation, Erik Janssen and healthcare innovation expert Gary Monk to debate …
In this special Crimes Against Innovation episode, host Nicola Hill hears two charges against the research system.   Professor Raj Chovatiya argues that the academic model is putting the brakes on innovation, squeezing creativity and collaboration. Meanwhile, Dr Joe Rastrick condemns the irrep…
In this episode, we ask a defining question: will multi-specific therapies revolutionize how we treat complex diseases? Host Nicola Hill is joined by Dr Joe Rastrick (UCB) and Professor Raj Chovatiya (Rosalind Franklin University) to examine whether medicines engineered to target multiple pathways …
Deep in the shadowy corridors of laboratories and the silent pages of medical journals, progress can falter, not for lack of brilliance, but because of the systems surrounding it. Ideas are delayed, discoveries are hidden, and bold thinking is quietly discouraged. This is Crimes Against Innovation.…
  In this episode, host Nicola Hill, is joined by Professor Maddie Parsons, Dean of Research Excellence Frameworks at King’s College London, and Dr Graham Price, Head of Global Clinical Development at UCB, to examine whether today’s trials are fit for tomorrow’s science.   Listen to our g…
Is scientific innovation enough to drive the future of gene therapy, or is patient engagement the missing key? Join host Nicola Hill as she explores this question with Laurence Woollard, a rare disease advocate, and UCB’s Global Patient Engagement Lead, Dr. Emma Lane. Together, they discuss the cri…
In the darkened corridors of laboratories and the silent pages of medical journals, there are stories rarely spoken about—tales of brilliance that burned too bright, and ideas that strayed into catastrophe. This is—Crimes Against Innovation.   Laurence Woollard and Dr. Emma Lane debate two pre…
In the shadowy corridors of laboratories and the silent pages of medical journals, there lie tales that have seldom been told. Tales of ambition that flew too close to the sun, of genius that turned into folly, and of innovation that... well, wasn't quite so innovative. This is—Crimes Against Innov…
In this episode, host Nicola Hill explores the hypothesis that fully virtualised decentralized clinical trials (DCT), that operate invisibly, will make traditional models obsolete within the next decade.   Joining her are Craig Lipset, Co-Chair of the Decentralized Trials and Research Alliance…
Aviso: O podcast e a arte incorporada nesta página são de UCB Biopharma , que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.